Research

The following research has been performed on the Reactor®:

1. (2002 Survey) A third-party survey conducted of 23 emergency room physicians and cardiologists regarding our early prototype and concept of how the Reactor® could improve open chest tube insertion.
2. (SAEM Presentation) – Researchers at the University of Connecticut compared the traditional open chest tube insertion vs the Reactor® in a IRB approved rib model. They found use of the Reactor® improves chest tube insertion…with its ease of use, faster time to insertion, and shorter length of incision when compared with traditional thoracostomy technique.
3. (The American Journal of Surgery) – Researchers at Madigan Army Medical Center published a revolutionary look at the traditional method for treating tension pneumothorax (needle decompression) showing the Reactor® to be significantly superior in time to resolution and final pressure. This research has been presented at the 2017 North Pacific Surgical Association, the 2018 Society for Military Surgeons at SAGES (1st place award), the 2018 Madigan Research Day (1st place award), and the 2018 Military Health System Research Symposium.

Research Ideas

Presently researchers are evaluating human, cadaver, mannequin and animal studies on the Reactor®.  Sharp Medical Products, LLC welcomes research on the Reactor®. If you have ideas for a research project that you would like to discuss please contact us at ideas@sharpmedicalproducts.com. Sharp Medical Products, LLC can on occasion provide support of varying degrees depending on the project and need.

The following research has been performed on O2MAXTM:

1. (SAEM)Researchers at A.T. Still University and Grady Memorial Hospital will present clinical data on O2MAXTM (a revolutionary face mask designed from the ‘ground up’) at the Society for Academic Medicine (SAEM) annual meeting, May 15 – 18, 2018, in Indianapolis, IN. The data will be available for publication after that date. A key finding of the study is a significantly higher amount of oxygen is delivered to patients compared to the standard leading simple oxygen masks currently on the market.